MDLN
Medline Inc. Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$32.12Close
$31.64 – $49.9952-week range
Nov 4, 2026Next report · before the open
Highlights
Cautions
- Results soon Nov 4, 2026, in 3 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
36%
1wk
down 5.8%
price change
1mo
down 7.4%
price change
12-month return
down 22%
total, dividends included
F-score
—
— Not assessed
Altman Z
—
Unknown
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
—
price / book
Earnings yield
—
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
—
year on year
EPS growth
—
latest quarter
Sales growth
up 12%
latest quarter · +1 pts
ROE
up 10776%
return on equity
Free cash margin
up 5%
$1.3B FCF
D/E
1.16
long-term debt / equity
Net debt / EBITDA
3.3×
Interest cover
—EBIT / interest
Trade setup
ATR%
3.6%
$1.14 a day · 2×ATR $29.84
RS
—
vs the universe
Trend
—
trend template
Relative volume
1.7×
vs 50-day average
Up/down volume
0.99
50 sessions
Implied move
—
no option chain · report Nov 4, 2026
Screen verdict
Did not qualify for any screen.
Warning signs
- Profit not backed by cash Reported profit of $1.2T came with $1.7B of operating cash flow. Profit that cash does not follow is the classic signature of aggressive accounting.
Last reported
Aug 5, 2026
Last shock
Aug 5, 2026-13% in one session3.0× volumeon results-12% since
Financials
- Gross 26%
- Net 4069%
- Free cash 5%
- Cash
- Long-term debt
| FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 16, 2025 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|
| Revenue | $23.2B | $25.5B | — | $28.4B |
| Gross margin | 25% | 27% | — | 26% |
| Operating income | $1.2B | $2.1B | — | $2.2B |
| Net income | $234.0M | $1.2B | $1.2B | $1.2T |
| Net margin | 1% | 5% | — | 4069% |
| Earnings per share | — | — | — | $1,428.40 |
| Free cash flow | $1.4B | $1.4B | — | $1.3B |
| Free cash margin | 6% | 6% | — | 5% |
| Cash | $1.6B | $199.0M | — | $1.9B |
| Long-term debt | — | $16.4B | — | $12.5B |
| Shareholders' equity | — | — | — | $10.7B |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 5, 2026 | Quarterly ↗ | Jun 27, 2026 | 39d |
| May 6, 2026 | Quarterly ↗ | Mar 28, 2026 | 39d |
| Feb 25, 2026 | Annual ↗ | Dec 31, 2025 | 56d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 21, 2026 | Regulation FD ↗ |
| Oct 15, 2026 | Director or officer change ↗ |
| Aug 5, 2026 | Results ↗ |
| Jul 9, 2026 | Director or officer change ↗ |
| Jun 12, 2026 | Shareholder vote ↗ |
| Jun 2, 2026 | Material agreement · New obligation · Other events ↗ |
| May 6, 2026 | Results ↗ |
| Feb 25, 2026 | Results ↗ |
| Dec 22, 2025 | Material agreement · Holder rights changed · Director or officer change · Charter or bylaws · Other events ↗ |